Sowell Financial Services’s Indaptus Therapeutics INDP Stock Holding History

Sowell Financial Services’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8	Closed	-$3K	–	1573
2021 Q1	$3K	Buy	+8	New	+$4.19K	﹤0.01%	2737

Other funds holding INDP

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Sowell Financial Services's INDP Position: Q2 2021 in Review

Sowell Financial Services sold out of Indaptus Therapeutics (INDP) in Q2 2021, closing a stake of 8 shares — an estimated $3K sold.

Sowell Financial Services first reported a position in INDP in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 10 funds tracked by Wall St. Rank hold INDP as of Q2 2021.

Sowell Financial Services reported no remaining Indaptus Therapeutics position as of Q2 2021 after selling out during the quarter.
Sowell Financial Services sold 8 Indaptus Therapeutics shares in Q2 2021, an estimated $3K.
Sowell Financial Services first reported a position in Indaptus Therapeutics in Q1 2021 and held it in 1 quarter.
Sowell Financial Services's Indaptus Therapeutics position peaked at $3K in Q1 2021.
10 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.